Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
02/16/1983 | EP0072080A2 Maltitol containing gel based systems |
02/16/1983 | EP0072021A2 Aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents, a process for preparing the same, and a solid medicinal oral dosage form containing an enteric coating prepared by using same |
02/16/1983 | EP0071995A2 Fat emulsion for parenteral nutrition |
02/16/1983 | EP0071974A2 Antimicrobial compositions for treating running open wounds |
02/16/1983 | EP0071879A2 Cream base |
02/15/1983 | US4374121 Macromolecular biologically active collagen articles |
02/15/1983 | US4374082 Method for making a pharmaceutical and/or nutritional dosage form |
02/15/1983 | CA1141295A1 Sustained release therapeutic compositions |
02/09/1983 | EP0070970A2 Low swelling starches as tablet disintegrants |
02/08/1983 | US4372944 Beeswax, petrolatum, triglyceryl diisostearate, squalane, mineral oil, isopropyl myristate, polyethylene, sorbitol |
02/08/1983 | US4372883 Process for the production of vaccine |
02/08/1983 | CA1140853A1 Cerebral therapeutic agent and its use |
02/03/1983 | WO1983000288A1 A stable aqueous, therapeutic insulin preparation and a process for preparing it |
02/01/1983 | US4371673 Cyclodextrin derivatives |
02/01/1983 | US4371523 Dicarboxy amino acid, stabilization |
02/01/1983 | US4371519 Methods of treating cellular tissue |
02/01/1983 | US4371518 Carriers for spermicidal substances |
02/01/1983 | US4371464 Dipeptide sweetener |
01/26/1983 | EP0070525A2 Fungicidal preparations for external use |
01/26/1983 | EP0070368A1 Composition of matter comprising an inclusion compound of p-hexadecylamino benzoic acid in cyclodextrin |
01/25/1983 | US4370322 Topically administrable pharmaceutical compositions containing anti-inflammatory steroids |
01/25/1983 | CA1140048A1 Etomidate-containing compositions |
01/20/1983 | WO1983000150A1 Glycosaminoglycan drug complexes |
01/20/1983 | WO1983000084A1 Pharmaceutical compositions for the treatment of skin |
01/19/1983 | EP0070178A2 Novel bendroflumethiazide formulations |
01/19/1983 | EP0069946A1 Oil, its preparation and its use, particularly in cosmetics |
01/18/1983 | US4369308 Low swelling starches as tablet disintegrants |
01/18/1983 | US4369182 Inflammation-preventing pharmaceutical composition of oral administration |
01/18/1983 | US4369175 Stable resinates as vasodilators |
01/18/1983 | US4369172 Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
01/18/1983 | CA1139667A1 Galenical compositions |
01/18/1983 | CA1139665A1 Corticosteroid formulations containing sebacate carrier |
01/18/1983 | CA1139664A1 Oleaginous emollient vehicle for steroid formulations |
01/12/1983 | EP0069512A2 Salts of N-substituted-2-pyrrolidone-4-carboxylic acids as humectants |
01/12/1983 | EP0069423A1 Composition for topical application to the body |
01/12/1983 | EP0069385A2 Use of eucalyptol for enhancing skin permeation of bioaffecting agents |
01/11/1983 | US4368188 Cosmetic toner formulation |
01/11/1983 | US4368187 Sensitive-skin care regime |
01/11/1983 | US4368149 Protein hybrid having cytotoxicity and process for the preparation thereof |
01/11/1983 | US4368138 Water soluble thymidine derivative |
01/11/1983 | CA1139306A1 Interferon stabilization |
01/05/1983 | EP0069097A2 Pharmaceutical mixture |
01/05/1983 | EP0068552A2 Topical antimicrobial composition |
01/05/1983 | EP0068450A2 Pharmaceutical forms for oral administration |
01/05/1983 | EP0068446A2 Process for the time controlled release of an active agent from preparations of this agent, particularly from pharmaceutical preparations |
01/05/1983 | EP0068191A2 Oral forms of dipyridamole |
01/04/1983 | US4367224 Antiinflammatory agents, skin disorders |
01/04/1983 | CA1138775A1 Suspension composition of benzocaine |
12/28/1982 | US4366310 Controlled release compositions |
12/28/1982 | US4366151 Oxyalkylated fatty acids and their use as solubilizers |
12/28/1982 | CA1138438A1 Immunochemical conjugates: method and composition |
12/22/1982 | EP0067671A2 Hydrogels |
12/22/1982 | EP0067658A2 Carboxyvinyl polymer urea gel compositions |
12/22/1982 | EP0067513A2 Pharmaceutical preparations containing TRH or its analogue |
12/21/1982 | US4365050 Wetting agents for contact lens solutions |
12/21/1982 | US4364930 Cosmetic or pharmaceutical compositions in the form of stable oil-in-water emulsions |
12/21/1982 | US4364928 Novel salts of ion exchange resins of the acid type |
12/15/1982 | EP0067029A2 Oxygen carrier |
12/15/1982 | EP0066861A1 Dianionic 5,5'-azobis-salicylic-acid composition |
12/15/1982 | EP0066684A1 Tricyclic oxygenated compounds derived from norbornane, and their use as perfuming ingredients |
12/14/1982 | US4363806 Pharmaceutical composition |
12/14/1982 | US4363758 Bonding an immunoglobulin and an antigen |
12/14/1982 | US4363669 With plant extracts gums |
12/07/1982 | CA1136988A1 Aqueous composition |
12/01/1982 | EP0065905A1 Stabilizing agents for live viruses for the preparation of vaccines, and stabilized vaccines containing these stabilizing agents |
11/30/1982 | CA1136550A1 Pharmaceutical composition containing thymidine |
11/25/1982 | WO1982004052A1 Method for the preparation of inclusion complexes derived from n-[1-phenyle-ethyle]-3,3-diphenyle-propylamine respectively from the hydrochloryde thereof and from cyclodextrine |
11/24/1982 | EP0065320A1 Coupling process of a medicament to a thiolated polypeptidic compound coming from a fragment of the tetanic toxine, and its uses |
11/23/1982 | US4360592 Coupling reagents for enzyme conjugates; immunoassay |
11/23/1982 | US4360590 Photographic material |
11/23/1982 | US4360523 Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide |
11/23/1982 | US4360518 Mefenamic or flufenamic acid with corticosteroid |
11/23/1982 | CA1136048A1 Stable injectable solutions of indoleacetic and indanacetic acid derivatives |
11/10/1982 | EP0064283A2 Stabilization of 1-substituted imidazole derivatives in talc |
11/09/1982 | US4358603 Acetal stabilized prostaglandin compositions |
11/09/1982 | CA1135188A1 Oxytetracycline compositions |
11/03/1982 | EP0063988A1 Anticancer medicaments containing a ricin A-chain associated with an antimelanoma antibody, and process for their preparation |
11/03/1982 | EP0063870A2 Cream preparation |
11/02/1982 | US4357353 Process for the production of an emulsifier based on lecithin and product thereof |
11/02/1982 | US4357273 Antitumor protein hybrid and process for the preparation thereof |
11/02/1982 | US4357259 Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres |
11/02/1982 | CA1134820A1 Triethyl citrate solutions of pge-type compounds |
11/02/1982 | CA1134747A1 Medicinal formulation |
11/02/1982 | CA1134746A1 Medicinal formulation |
10/27/1982 | EP0063373A1 Cell-specific glycopeptide ligands |
10/27/1982 | EP0063367A1 Acetal stabilized prostaglandin compositions |
10/27/1982 | EP0063328A2 Compositions containing secretin and method for preventing the adsorption of secretin |
10/26/1982 | US4356166 Time-release chemical delivery system |
10/26/1982 | US4356165 Bupropion radioimmunoassay, and kit |
10/26/1982 | US4356117 Chemical modifications of proteins which induce new receptor specificities and therefore elicit new effects in cells |
10/26/1982 | CA1134276A1 Phosphatide-lower alkanolamine complex for topical application |
10/26/1982 | CA1134271A1 Use of antioestrogens and antigonadotropically active antiandrogens for the prophylaxis and therapy of prostate hyperplasia and pharmaceutical preparations and packs suitable for such use |
10/26/1982 | CA1134270A1 Prostaglandin vasodilators and hypotensive agents for administration topically or by injection |
10/20/1982 | EP0063091A2 Mixtures of snake venoms for treatment of neurological and related disorders |
10/20/1982 | EP0062896A2 Skin care base material for external use |
10/19/1982 | US4355179 Radioactive nuclide labeled propiophenone compounds |
10/19/1982 | US4355046 Dermatologic and cosmetic ointment base |
10/19/1982 | US4355020 Thixotropic aluminum hydroxide chloride and medical and other applications thereof |
10/13/1982 | EP0062578A1 Therapeutical composition as a topic digestant |
10/13/1982 | EP0062225A2 Spray-dried vitamin E powder |